News Releases

Generate Life Sciences Announces Schedule of Presentations at the ASRM and AABB Annual Meetings
The new data being presented further underscores Generate's commitment to supporting regenerative medicine research and improving quality metrics to better serve its families

LOS ANGELES, Sep. 30, 2021 /PRNewswire/ -- Generate Life Sciences, a leading reproductive medicine and stem cell research organization, will have multiple presentations during the American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo, held in-person and virtually from October 17-20, 2021, and the AABB (formerly known as the American Association of Blood Banks) Annual Meeting, held virtually October 17-19, 2021.

The Generate Life Sciences team will present two abstracts at the ASRM meeting and one poster at AABB. Collectively, the presentations will detail: (1) the potential use of mesenchymal stem cells (MSCs) derived from umbilical cord tissue to treat premature ovarian insufficiency; (2) computer-assisted analysis of sperm quality from samples collected from donors before, during and after asymptomatic COVID-19 infection; and (3) rapid implementation of a modular cleanroom that meets ISO-7 certification standards and is intended for the isolation and expansion of MSCs from cord tissue previously cryopreserved as a composite material.

"As part of our commitment to provide the most cutting-edge research that moves the industry forward, we are pleased to share our latest research at ASRM and AABB," said Jaime Shamonki, MD, Chief Medical Officer of Generate Life Sciences. "These data highlight a portion of our ongoing research to provide more insight into the potential of newborn stem cells for therapeutic and regenerative treatments and also highlight our efforts to improve quality practices that can transform the entire family health industry."

The following presentations are scheduled:

American Society for Reproductive Medicine

  • Characterization of Umbilical Cord Tissue Mesenchymal Stem Cells Based on Donor Sex for Premature Ovarian Insufficiency
    Presenting Author: Katherine S. Brown, Ph.D
    Date: Wednesday, October 20, 2021
    Time: 6:30 a.m. - 7:45 a.m. ET
    Location: Online
  • Semen Analysis Parameters Do Not Change During Active Covid Infection In Qualified Sperm Donors
    Presenting Author: Christopher Antonelli
    Date: Wednesday, October 20, 2021
    Time: 11:45 a.m. - 12 p.m. ET
    Location: Baltimore Convention Center - 310


  • Establishment of a Modular Cleanroom for cGMP Production of a Cord Tissue MSCs Intended for Clinical Use
    Presenting Author: Matthew L. Skiles, Ph.D.
    Date: October 17-19, 2021
    Location: Online

Full information on ASRM presentations are available here and AABB presentations can be found here.

About Generate Life Sciences

Generate Life Sciences™ is a global life sciences company helping families setting out to grow and protect their future, through guidance anchored in scientific advancements and services ranging from preconception into adulthood. Our longstanding brands — which include CBR® (Cord Blood Registry®), Insception Lifebank, Cells for Life, Cell Care, California Cryobank™, Donor Egg Bank USA™, NW Cryobank™, ReadyGen™, Kitazato USA™, and Donor Application™ — are pioneering leaders that have helped nearly one million families through reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services. Headquartered in Los Angeles, Generate operates facilities spanning from the United States and Canada to Australia, alongside frozen donor gamete distribution to more than 40 countries. Generate is a portfolio company of GI Partners, a private investment firm based in San Francisco.

Media Contact
Zuri McClelland

SOURCE Generate Life Sciences